Raymond T Chung, MD, FAASLD
Biography
Dr. Raymond Chung is Zhou Family Endowed Chair and Chief of Gastroenterology and Hepatology at Mass General Brigham. He is also Professor of Medicine at Harvard Medical School. He has been an internationally recognized leader in viral hepatitis research in the areas of virology, pathogenesis, and hepatocarcinogenesis. He directs an NIH Cooperative Center for Human Immunology and was co-PI of the Harvard HBV Consortium of the NIH HBV Research Network. He is contact PI of the MGH GI Division's T32 Training Grant and holds several NIH R01, U19 and U01 grants. He has also held an NIH K24 Mentorship Award. He has served as Associate Editor of Hepatology, Gastroenterology, and the Journal of Infectious Diseases. He was a founding co-Chair of the AASLD/IDSA HCV Guidance panel, co-Chair of the AASLD COVID-19 Task Force, and co-Director of the AGA/AASLD Career Development Workshop. He also served as Co-Chair of the 24th International Symposium on HCV in 2017. He has served on the Governing Board of the AASLD as Councilor, President-Elect, and, in 2021, as President. He has served as Associate Editor and currently co-Editor of Sleisenger and Fordtran's Gastrointestinal and Liver Disease. He has been elected to the Association of American Physicians and has authored more than 700 original articles, reviews, and editorials. His lab is currently focused on the mechanisms by which HIV accelerates HBV-and MASH-related fibrogenesis. He is also directing work on evaluating the chemopreventive effects of statins on liver disease progression and HCC.